REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor Linking Fibrinolysis and Age‐Related Subclinical and Clinical Conditions
Open Access
- 7 July 2010
- journal article
- review article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 28 (5), e72-e91
- https://doi.org/10.1111/j.1755-5922.2010.00171.x
Abstract
Introduction: The close relationship existing between aging and thrombosis has growingly been studied in this last decade. The age‐related development of a prothrombotic imbalance in the fibrinolysis homeostasis has been hypothesized as the basis of this increased cardiovascular and cerebrovascular risk. Fibrinolysis is the result of the interactions among multiple plasminogen activators and inhibitors constituting the enzymatic cascade, and ultimately leading to the degradation of fibrin. The plasminogen activator system plays a key role in a wide range of physiological and pathological processes. Methods: Narrative review. Results: Plasminogen activator inhibitor‐1 (PAI‐1) is a member of the superfamily of serine‐protease inhibitors (or serpins), and the principal inhibitor of both the tissue‐type and the urokinase‐type plasminogen activator, the two plasminogen activators able to activate plasminogen. Current evidence describing the central role played by PAI‐1 in a number of age‐related subclinical (i.e., inflammation, atherosclerosis, insulin resistance) and clinical (i.e., obesity, comorbidities, Werner syndrome) conditions is presented. Conclusions: Despite some controversial and unclear issues, PAI‐1 represents an extremely promising marker that may become a biological parameter to be progressively considered in the prognostic evaluation, in the disease monitoring, and as treatment target of age‐related conditions in the future.Keywords
This publication has 180 references indexed in Scilit:
- Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weaknessBiogerontology, 2008
- Hypercoagulability in the metabolic syndromeCurrent Opinion in Pharmacology, 2005
- Exercise training enhances endogenous fibrinolysis in peripheral arterial diseaseJournal of Vascular Surgery, 2004
- Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α–activated human peritoneal mesothelial cellsKidney International, 2003
- Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-α?Atherosclerosis, 1999
- Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in womenInternational Journal of Obesity, 1998
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsThe New England Journal of Medicine, 1989
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionThe New England Journal of Medicine, 1985
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathThe New England Journal of Medicine, 1984
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionThe New England Journal of Medicine, 1980